A record number of procedures performed at HUS Neurosurgery in 2024 – waiting list is now under control
HUS Neurosurgery has been able to significantly shorten their surgery waiting list. In 2024, a record number of surgeries were performed, and more and more operations are ambulatory.

Access to neurosurgical care has significantly improved at HUS.
Currently, there are only 13 patients who have waited for their surgery longer than the guaranteed treatment time, which is six months, compared to more than 600 in fall 2023.
In total, 346 patients are on the neurosurgery waiting list within the care guarantee, whereas in August 2023 there were 1350 of them.
“The waiting list situation has greatly improved, and we estimate that by March nobody has to wait longer than the guaranteed maximum waiting time,” says Head Physician Mika Niemelä, head of neurosurgery from HUS Neurocenter.
The majority of the patients who have been on the waiting list for a long time need spinal fusion surgery.
The number of operations in neurosurgery hit a record high in 2024.
“Last year, we performed more surgeries than ever in our history; a total of 3850 procedures. The number includes neurosurgery for children and intravenous procedures,” Niemelä explains.
More ambulatory surgeries and improved efficiency
The number of ambulatory surgeries has increased by 70%.
“We now treat 50% of cervical spine patients and 60% of our non-urgent lumbar spine patients in ambulatory surgery. The most significant factors that enabled us to shorten the waiting list were increasing the number of ambulatory surgeries, improved efficiency at the ward, and shorter treatment times,” says Niemelä.
Access to neurosurgery declined during the COVID-19 pandemic and at the turn of the year 2022–2023. When the Bridge Hospital opened in early 2023, only three of the six operating rooms intended for neurosurgery were in use due to a nursing shortage.
Clearing the waiting list was the number one goal for 2024.
“We put significant effort in recruiting and training nursing professionals, and together with the Center for Perioperative and Intensive Care, we got more staff in the operating rooms and our ward. Together with the OR staff, our neurosurgeons were prepared to use all of the available operating room time as efficiently as possible, and we did everything we could to avoid cancelling surgeries. Our ward staff was also able to meet the increasing demand by developing their work,” explains Nina Forss, director of Neurocenter.
Now all the six operating rooms in the Bridge Hospital are in full use. Surgeries also continue in Hospital Orton until April. Children's surgeries are performed in New Children's Hospital.
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
Keywords
Contacts
Mika NiemeläHead of Neurosurgery, Head Physician, Neurocenter
mika.niemela@hus.fiImages

About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Gips räcker vid frakturer på mediala humerusepikondylen vid armbågsleden hos barn9.9.2025 09:55:56 EEST | Pressmeddelande
I en nyligen publicerad studie framgick det att gipsning som behandling vid frakturer på mediala humerusepikondylen hos barn är en lika effektiv behandlingsform som operation. De resultat som man nu fått stöder gipsbehandling som primär behandlingsform och behandlingen kan förenhetligas på riksnivå.
Kipsi riittää lasten kyynärnivelen koukistajalisäkkeen murtumissa9.9.2025 09:55:56 EEST | Tiedote
Juuri julkaistussa tutkimuksessa selvisi, että lasten kyynärnivelen koukistajalisäkkeen murtumien hoidossa kipsaus on yhtä tehokas hoitomuoto kuin leikkaus. Nyt saadut tulokset tukevat kipsihoidon käyttöä ensisijaisena hoitomuotona, ja hoitoa voidaan yhtenäistää kansallisesti.
Den nyaste ekonomiska prognosen för hela 2025: HUS är på väg att uppnå sina ekonomiska mål för 20258.9.2025 12:09:48 EEST | Pressmeddelande
HUS-sammanslutningens styrelse behandlade på sitt möte verksamheten och ekonomin i januari–juli samt den nyaste årsprognosen för hela 2025. HUS-sammanslutningens operativa resultat beräknas uppvisa ett överskott på 0,1 miljoner euro. Sammanslutningens styrelse fastställde också investeringsplanen och investeringsprogrammet för de kommande åren.
Koko vuoden 2025 uusin talousennuste: HUS pääsemässä vuonna 2025 taloudellisiin tavoitteisiinsa8.9.2025 12:09:48 EEST | Tiedote
HUSin yhtymähallitus käsitteli kokouksessaan tammi–heinäkuun taloutta sekä uusinta koko vuoden 2025 vuosiennustetta. HUS-yhtymän operatiivisen tuloksen ennustetaan päätyvän 0,1 miljoonaa euroa ylijäämäiseksi. Yhtymähallitus vahvisti myös tulevien vuosien investointisuunnitelman ja -ohjelman.
Förebyggande av RS-virusinfektion hos spädbarn inleds på HUS sjukhus3.9.2025 14:17:24 EEST | Pressmeddelande
RS-virus (respiratory syncytial virus, RSV) är den vanligaste orsaken till luftvägsinfektioner som kräver sjukhusvård hos små barn. HUS erbjuder en antikropp som utvecklats mot RS-virus, det vill säga nirsevimab åt nyfödda och barn under ett år som hör till riskgrupperna.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom